Navigation Links
Shareholders to Challenge Johnson & Johnson's Support for Left-Wing Policy Agenda: CEO William C. Weldon to Be Questioned on Firm's Failure to Disclose Financial Information on Firm's ObamaCare Lobbying It Pledged to Release Last Year

WASHINGTON, April 27, 2011 /PRNewswire-USNewswire/ -- The National Center for Public Policy Research will grill Johnson & Johnson executives over the firm's lobbying for bigger government Thursday, April 28 at the company's annual shareholder meeting in New Brunswick, New Jersey. National Center General Counsel Justin Danhof will demand specific answers about the company's pro-ObamaCare lobbying that Johnson & Johnson CEO William C. Weldon promised to provide but failed to do.

A National Center for Public Policy Research/FreedomWorks poll shows the pharmaceutical giant is vulnerable to a boycott by conservatives.

Johnson & Johnson's favorability among conservatives fell from 69 percent to 19 percent and from 60 percent to 8 percent among tea party activists after participants were informed of the company's lobbying or ObamaCare and cap-and-trade.

In addition to supporting Obama's health care takeover, Johnson & Johnson is a member of the U.S. Climate Action Partnership, a left-wing lobbying coalition formed to promote job-killing global warming regulations such as cap-and-trade.

"From the ObamaCare bill to cap-and-trade legislation, President Obama has been able to count on Johnson & Johnson for aid and comfort. By supporting Obama's economically disastrous policies, Johnson & Johnson is working to increase the power and scope of the federal government at the expense of American liberties and values. Weldon should explain why he is risking Johnson & Johnson's reputation, goodwill and shareholder value to promote a big-government agenda," said Danhof.

Johnson & Johnson is a member of the Pharmaceutical Researchers and Manufacturers of America (PhRMA), which aggressively lobbied for President Obama's health care takeover. At last year's Johnson & Johnson shareholder meeting, Weldon promised National Center Free Enterprise Project Director Dr. Tom Borelli that the firm would disclose precisely how much shareholder money his company spent promoting the ObamaCare legislation.

"Despite repeated requests from the National Center and his own pledge in front of shareholders last year, Weldon still refuses to release those figures. It is time for Weldon to come clean with company stakeholders - many of whom undoubtedly oppose the ObamaCare agenda," said Danhof.

At last year's shareholder meeting, Weldon told Dr. Borelli, "I don't think there is any reputational damage" due to the company's lobbying for ObamaCare's passage.

"The poll numbers don't lie. Tea party activists and conservatives have indicated a willingness to vote with their wallets and forgo Johnson & Johnson products. That could result in real economic loss for shareholders. Weldon needs to explain why he continues to oversee Johnson & Johnson's support of President Obama's unpopular policies instead of upholding his fiduciary duty and protecting the shareholders' investments in the company he is tasked to run," Danhof stated.

To view a transcript of CEO Weldon's conversation with Dr. Borelli at the 2010 shareholder meeting and subsequent communications, see:

For more details on the National Center for Public Policy Research/FreedomWorks poll, see:

CONTACT: David Almasi, +1-202-543-4110 x11, +1-703-568-4727,, or Judy Kent, +1-703-759-7476,

SOURCE National Center for Public Policy Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Announces Chairmans Letter to Shareholders
2. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
3. Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction
4. AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)
5. Omni Bio Pharmaceutical, Incs. CEO Issues Letter to Shareholders
6. Tongjitang Chinese Medicines Company Shareholders Vote to Approve Merger
7. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
8. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
9. Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders
10. Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share
11. Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
Post Your Comments:
(Date:11/27/2015)... Pays-Bas, November 27, 2015 ... traitement photodynamique au Bremachlorin contre le cancer avancé. ... consistant à combiner l,immunothérapie au traitement photodynamique au ... --> Une nouvelle approche consistant à ... le cancer avancé.    Clinical ...
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... Niederlande, November 27, 2015 ... bei fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... ... The rapid speed at which Americans are aging is ... needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. Health ... of this equation: 80 percent of medical care occurs in the home, by ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):